Fangsheng Pharmaceutical Announcement: The holding subsidiary, Guangdong Fangsheng Ronghua Pharmaceutical Co., Ltd., has received the “Drug Production License” issued by the Guangdong Provincial Drug Administration. It approves Fangsheng Ronghua as the drug marketing authorization holder, with Fangsheng Pharmaceutical acting as the entrusted party, and the entrusted product is RuLugoLi tablets.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Fangsheng Pharmaceutical: Subsidiary Obtains "Drug Manufacturing License"
Fangsheng Pharmaceutical Announcement: The holding subsidiary, Guangdong Fangsheng Ronghua Pharmaceutical Co., Ltd., has received the “Drug Production License” issued by the Guangdong Provincial Drug Administration. It approves Fangsheng Ronghua as the drug marketing authorization holder, with Fangsheng Pharmaceutical acting as the entrusted party, and the entrusted product is RuLugoLi tablets.